Original Air Date: April 16, 2024, 1:00 PM - 2:00 PM Eastern Time

Speaker: Ehsan Samei, PhD, DABR, FAAPM, FSPIE, FAIMBE, FIOMP, FACR, Chief Imaging Physicist, and director of Center for Virtual Imaging Trials, Duke University

Sponsored by Imalogix 

CMS recently instituted a new rule pertaining to “Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults.” Reviewing the new rule, practitioners have found many ambiguities the interpretations to which can significantly impact its implementation. To help practitioners and implementers of the new rule, the AAPM recently commissioned an intersocietal panel of experienced, practical, and committed experts in CT radiation dose, image quality, and patient care including industry representatives, academics, and clinical practitioners from professional societies. The panel consolidated a list of ambiguities within the current CMS rule and took upon itself to provide educated recommendations for each. This presentation offers a summary of the deliberations of this effort, and puts that into a cohesive strategy (grounded by the consensus statement from a recent Quality Measures Roundtable representing a broad spectrum of stakeholders) by which the quality, safety, and consistency of medical CT imaging can be assured.

Webinar attendees will:

1. Understand the goal of the new CMS rule on Excessive Radiation Dose or Inadequate Image Quality.
2. Understand the critical ambiguities in the implementation of the new rule and the means and limitations by which such ambiguities can be mitigated.

Note: No CE credit is available for this archived webinar

Presented by Melody Mulaik, MSHS, FAHRA, CRA, RCC, RCCIR, CPC, COC
President, Revenue Cycle Coding Strategies

This dynamic session is for individuals responsible for any portion of the charge capture, coding, documentation, billing, and account follow-up of radiology services. All the 2024 radiology coding updates will be reviewed in detail as well as other key items of concern related to imaging services, including but not limited to, AI, supervision, reimbursement, and audit concerns. Radiology administrators as well as professionals involved in radiology compliance and revenue cycle will gain the information that they need to ensure correct coding and compliance for their organizations. It is recommended that appropriate individuals from Compliance and Finance be invited to ensure consistency and accuracy within the entire organization.

You will learn:

• 2024 Coding Updates – Diagnostic, Interventional and E/M
• Modality Specific Areas of Concern – Coding, Edits and Audit Targets
• Regulatory Updates Including Supervision, AUC and More!

AHRA Member: $99.00
Non-Member: $249.00 - includes membership thru 12/31/24. 

Click here to learn more about the benefits of AHRA Membership.

This webinar has been approved for 1.5 Category A ARRT continuing education credits.

AHRA Best of 2023
Curated content from the AHRA 2023 Annual Meeting and live webinars; highlights the best professional education, advice, and innovative thinking offered by AHRA in 2023.

Sessions Include:

• Annual Meeting 2023
  • E/M for Radiology: Don’t Miss Out
  • Psychological Safety: How to Create Fearless Teams
  • Billing and Compliance for Radiology Extenders
  • Remote MRI Scanning: Critical Components for Safe Imaging
  • Simplified MRI Implant/Device Risk-Assessment
  • Leadership Buffet
• CLIMB 2023
  • Enhanced Care Coordination Drives Increased CT Asset Utilization
  • Trauma-Informed Resilient Leader
  • Using Patient Feedback as A Catalyst for Change
• On-Demand Webinars:
  • Countdown to 2024 - An FDA Regulatory Update of the Mammography Quality Standards (MQSA)
  • Illuminating Diversity: Asian American Leaders in Radiology - A DEI Conversation
  • The Role of the Modern Medical Physicist in Diagnostic Imaging
  • Mammography System Evaluations – A Physicist Weighs In
  • New Concepts in MRI Contrast Safety and Management

Up to 5.0 ARRT Category A CE credits are available for this program.

AHRA Member: FREE!
Non-Member: $125.00
Click here to learn more about the benefits of AHRA Membership.

Generously Sponsored by Bayer

AHRA January/February 2024 Quick Credit

AHRA November/December 2023 Quick Credit

AHRA November/December 2023 Quick Credit

AHRA September/October 2023 Quick Credit

AHRA September/October 2023 Quick Credit

Pamela Habib, MD, Head of Commercial Development, Bayer Digital Solutions
Aaron Sullivan, Head of Business Development, Bayer Digital Solutions

Sponsored by: Bayer

Over the past few years, the field of AI in medical imaging has undergone a rapid but steady transformation. AI can now achieve things in radiology that few people thought possible a mere decade ago. The field is also gradually overcoming one of its most significant perceived hurdles - regulatory approval. In addition, while fear and skepticism dominated radiologists’ perception of the future of AI in their specialty a few years ago, this is no longer the case. AI-based solutions in medical imaging could improve and accelerate the detection of disease, generate in-depth risk assessment of disease development and progression, and may reduce subjectivity in the interpretation of medical imaging data. Learn more about AI in Medical Imaging, the what, how, and why in this session.

In this webinar, attendees will learn how to:

• Understand the current state of AI in medical imaging, before, during, and after image acquisition
• Learn about funding, adoption, and regulatory landscape
• Gain insight into the future steps & challenges of AI in medical imaging

Note: No CE credit is available for this archived webinar

Presented by Ari D. Goldberg, MD, PhD, Medical Director, Body Imaging, Medical Director, MRI, Loyola University Medical Center

MRI contrast agents continue to be developed, with a focus on continued improvements in stability and safety, as well as maximization of image clarity. These distinctions rest in the molecular structure of the particular gadolinium-based contrast agent. Understanding the relative safety and efficacy of these agents is important in the radiologic management of patients. During this webinar, we’ll look closely at novel advances related to MRI contrast safety and management; understanding the risks associated with various agents as well as their efficacy.

In this webinar, attendees will learn how to:

• Identify the different Gadolinium-based contrast agent classifications.
• Explain how Gadolinium-based contrast agent stability and safety is evaluated.
• Describe the concept of gadolinium-based contrast agent "relaxivity".

AHRA Member: free to members
Non-Member: $25.00
Click here to learn more about the benefits of AHRA Membership.